Practice-Based Intervention for Urinary Incontinence
(OPTIMA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to improve how primary care doctors manage urinary incontinence (UI) in women. The goal is to determine if training and support tools for doctors, such as Academic Detailing (a practice-based intervention), can lead to better care and reduce the need for specialist visits. It also examines whether this approach can improve symptoms and quality of life for patients. Women who have experienced urinary leakage and are willing to discuss it with their primary care doctor might be a good fit. As an unphased trial, this study offers participants the opportunity to contribute to innovative research that could enhance primary care for urinary incontinence.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your primary care provider.
What prior data suggests that this practice-based intervention is safe for improving urinary incontinence care?
Research shows that the treatments studied in this trial, such as personalized education for doctors and electronic decision-making tools, have positively impacted patient care. Personalized education has improved medication prescribing in other studies, suggesting it might help primary care providers better manage urinary incontinence.
Studies on electronic decision-making tools indicate they can enhance patient outcomes by aiding healthcare providers in making better decisions. Although specific safety data for these tools related to urinary incontinence isn't detailed, they have generally been well-received in other healthcare settings.
Another part of the trial involves Advanced Practice Providers (APPs) working alongside doctors. Other studies have used this approach to successfully reduce the workload on primary care providers and improve care for urinary incontinence.
Lastly, electronic referral systems have been studied and found to enhance patient care efficiency. While specific safety outcomes for urinary incontinence weren't highlighted, these tools are generally considered safe and effective in improving healthcare processes.
Overall, each part of the intervention has been used in various healthcare settings with positive results, suggesting they are likely safe and well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it introduces a comprehensive approach to managing urinary incontinence. Unlike traditional treatments that might focus solely on medication or lifestyle changes, this intervention combines several innovative strategies: academic detailing for physician education, electronic clinical decision support to streamline care, electronic referral systems for better patient management, and co-management by advanced practice providers for personalized patient education. This multifaceted approach aims to enhance the overall quality of care, improve patient outcomes, and could potentially set a new standard in managing urinary incontinence effectively.
What evidence suggests that this practice-based intervention is effective for improving urinary incontinence care?
This trial will evaluate a practice-based intervention for urinary incontinence, incorporating several strategies. Research has shown that educating healthcare providers through academic detailing can improve care for women with urinary incontinence (UI). Studies have found that this method not only enhances patient outcomes but is also cost-effective. In this trial, some participants will share care responsibilities with Advanced Practice Providers (APPs), who educate patients and improve care quality. Additionally, electronic tools that support doctors in making treatment decisions can lead to better patient results. The trial will also assess electronic referral systems, which simplify access to specialist care and have improved outcomes for patients with UI. Together, these strategies aim to enhance the quality of care and patient experiences with urinary incontinence.678910
Are You a Good Fit for This Trial?
This trial is for adult women over 18 who speak English or Spanish and have urinary incontinence. They must confirm their condition with a screening tool and agree to participate. Primary care physicians from certain sites can also join, provided they're part of the recruited offices.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of a practice-based intervention involving physician education, electronic decision support, and patient education/co-management by an advanced practice provider
Crossover Validation
Control group receives the intervention to validate improvements in patient care and outcomes
Follow-up
Participants are monitored for safety and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Academic Detailing
- APP Co-management
- Electronic Clinical Decision Support
- Electronic Referral
Academic Detailing is already approved in United States for the following indications:
- Improving quality of incontinence care
- Reducing utilization of specialist care for urinary incontinence
- Enhancing patient outcomes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
RAND
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Cedars-Sinai Medical Center
Collaborator
University of California, Los Angeles
Collaborator
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborator